cidofovir anhydrous has been researched along with Kidney Diseases in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (7.69) | 18.2507 |
| 2000's | 12 (46.15) | 29.6817 |
| 2010's | 11 (42.31) | 24.3611 |
| 2020's | 1 (3.85) | 2.80 |
| Authors | Studies |
|---|---|
| Beck, R; Guthoff, M; Heyne, N; Mühlbacher, T; Nadalin, S | 1 |
| DeVos, JM; Gaber, AO; Gaber, LW; Knight, RJ; Moore, LW; Patel, SJ | 1 |
| Akbaş, SH; Akkaya, B; Akman, S; Cağla Doğan, S; Colak, D; Comak, E; Dinçkan, A; Koyun, M; Mutlu, D; Mutlu, E; Sağlık, I; Süleymanlar, G; Uslu Gökçeoğlu, A | 1 |
| Astor, BC; Djamali, A; Mandelbrot, D; Mohamed, M; Muth, B; Panzer, SE; Parajuli, S; Zhong, W | 1 |
| Araya, CE; Dharnidharka, VR; Fennell, RS; Lew, JF; Neiberger, RE | 1 |
| Acott, PD | 1 |
| Chang, HR; Lian, JD; Wu, SW | 1 |
| Bhadri, VA; Lee-Horn, L; Shaw, PJ | 1 |
| Anglicheau, D; Bererhi, L; Burgard, M; Legendre, C; Martinez, F; Noel, LH; Pallet, N; Quamouss, O; Rabant, M; Rouzioux, C; Thervet, E | 1 |
| Egli, A; Helmersen, DS; Hirsch, HH; Johnson, A; Taub, K | 1 |
| Bellizzi, J; Desai, P; El-Meanawy, A; He, C; Novoa-Takara, L; Sujeet, K; Vasudev, B | 1 |
| Hakeem, A; Sharma, A; Sharma, H | 1 |
| Basdemir, G; Bayirli Turan, D; Dheir, H; Gurkan, A; Kacar, S; Sahin, S; Turunc, V; Uyar, M | 1 |
| Abitbol, C; Bruce, JH; Chandar, J; Garcia-Buitrago, MT; Pereira, T; Rojas, CP; Rusconi, P; Seeherunvong, W; Zilleruelò, G | 1 |
| Chapman, JR; Craig, JC; Howard, K; Hua, DK; Wong, G | 1 |
| Gao, Y; Momper, JD; Randhawa, PS; Schonder, KS; Shapiro, R; Venkataramanan, R; Zhao, Y | 1 |
| Beattie, TJ; Ellis, D; Gonwa, T; Green, MD; Moritz, ML; Saxena, M; Scantlebury, V; Shapiro, R; Singh Randhawa, P; Tuzuner, A; Vats, A | 1 |
| Kaltenis, P | 1 |
| Hirsch, HH; Steiger, J | 1 |
| Bowden, S; Cooper, JE; Lim, WH; Mathew, TH; Russ, GR | 1 |
| Haller, H; Mengel, M; Niedermeyer, J; Schwarz, A | 1 |
| Cosio, FG; Fidler, ME; Gloor, JM; Griffin, MD; Khamash, HA; Lager, DJ; Larson, TS; Lewin, M; Mahale, AS; Rule, AD; Schwab, TR; Stegall, MD; Textor, SC; Wadei, HM | 1 |
| Chandraker, A; Josephson, MA; Randhawa, PS; Williams, JW | 1 |
| Akioka, K; Kaihara, S; Nobori, S; Okamoto, M; Ushigome, H; Yoshimura, N | 1 |
3 review(s) available for cidofovir anhydrous and Kidney Diseases
| Article | Year |
|---|---|
[BK virus-associated nephropathy].
Topics: Adult; Age Factors; Antiviral Agents; BK Virus; Child; Cidofovir; Cytosine; Female; Graft Rejection; Humans; Infant; Kidney Diseases; Kidney Transplantation; Male; Organophosphonates; Organophosphorus Compounds; Polyomavirus Infections; Pregnancy; Time Factors; Tumor Virus Infections | 2003 |
Polyomavirus BK.
Topics: Antiviral Agents; BK Virus; Cidofovir; Cytosine; Humans; Immunocompromised Host; Kidney Diseases; Kidney Transplantation; Organophosphonates; Organophosphorus Compounds; Polyomavirus Infections; Tumor Virus Infections | 2003 |
Polyomavirus-associated nephropathy: update on antiviral strategies.
Topics: Animals; Antiviral Agents; Cidofovir; Cytosine; Humans; Isoxazoles; Kidney Diseases; Kidney Transplantation; Leflunomide; Organophosphonates; Polyomavirus; Polyomavirus Infections; Quinolones | 2006 |
2 trial(s) available for cidofovir anhydrous and Kidney Diseases
| Article | Year |
|---|---|
The effect of low-dose cidofovir on the long-term outcome of polyomavirus-associated nephropathy in renal transplant recipients.
Topics: Adult; Aged; Antiviral Agents; Cidofovir; Cytosine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Organophosphonates; Polyomavirus; Polyomavirus Infections; Treatment Outcome; Tumor Virus Infections | 2009 |
Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: the HPMPC peripheral cytomegalovirus retinitis trial. A randomized, controlled trial. Studies of Ocular complications of AIDS Research Group in Collaboration with the AIDS Clinical
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Combined Modality Therapy; Cytomegalovirus Retinitis; Cytosine; Disease Progression; Drug Administration Schedule; Female; Fluid Therapy; Humans; Kidney Diseases; Male; Organophosphonates; Organophosphorus Compounds; Probenecid; Prospective Studies; Renal Agents; Visual Acuity | 1997 |
21 other study(ies) available for cidofovir anhydrous and Kidney Diseases
| Article | Year |
|---|---|
Low-dose cidofovir and conversion to mTOR-based immunosuppression in polyomavirus-associated nephropathy.
Topics: Adult; Antiviral Agents; Biopsy; Cidofovir; Humans; Immunosuppression Therapy; Kidney; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Polyomavirus; Polyomavirus Infections; Retrospective Studies; TOR Serine-Threonine Kinases; Tumor Virus Infections | 2020 |
Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy: a single-center retrospective analysis.
Topics: Adult; Antiviral Agents; Biopsy; BK Virus; Cidofovir; Cytosine; Early Diagnosis; Female; Glomerular Filtration Rate; Graft Survival; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Kidney Diseases; Kidney Transplantation; Logistic Models; Male; Mass Screening; Middle Aged; Multivariate Analysis; Organophosphonates; Polyomavirus Infections; Predictive Value of Tests; Retrospective Studies; Risk Assessment; Risk Factors; Texas; Time Factors; Tumor Virus Infections; Viral Load; Viremia; Young Adult | 2013 |
[BK virus infections in pediatric kidney transplant recipients].
Topics: Adolescent; Antiviral Agents; BK Virus; Child; Cidofovir; Cytosine; DNA, Viral; Female; Graft Rejection; Humans; Immunosuppressive Agents; Isoxazoles; Kidney Diseases; Kidney Transplantation; Leflunomide; Male; Organophosphonates; Polyomavirus Infections; Tumor Virus Infections; Turkey | 2013 |
In kidney transplant recipients with BK polyomavirus infection, early BK nephropathy, microvascular inflammation, and serum creatinine are risk factors for graft loss.
Topics: Adult; Antiviral Agents; BK Virus; Cidofovir; Creatinine; Cytosine; Female; Graft Rejection; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Kidney; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Organophosphonates; Plasma Exchange; Polyomavirus Infections; Prognosis; Risk Factors; Tumor Virus Infections; Viremia | 2016 |
Intermediate dose cidofovir does not cause additive nephrotoxicity in BK virus allograft nephropathy.
Topics: Adolescent; Adult; Antiviral Agents; BK Virus; Child; Child, Preschool; Cidofovir; Cohort Studies; Cytosine; Disease Progression; Female; Humans; Kidney Diseases; Kidney Transplantation; Male; Organophosphonates; Retrospective Studies | 2008 |
Current treatment of polyoma BK nephropathy in pediatric renal transplant patients.
Topics: BK Virus; Child; Cidofovir; Ciprofloxacin; Cytosine; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Organophosphonates; Polyomavirus | 2008 |
Safety and tolerability of cidofovir in high-risk pediatric patients.
Topics: Adenovirus Infections, Human; Adenoviruses, Human; Adolescent; Adult; Antiviral Agents; Child; Child, Preschool; Cidofovir; Cytosine; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Kidney Diseases; Male; Organophosphonates; Treatment Outcome; Young Adult | 2009 |
Cidofovir may be deleterious in BK virus-associated nephropathy.
Topics: Antiviral Agents; BK Virus; Cidofovir; Cytosine; Graft Survival; Humans; Kidney Diseases; Kidney Transplantation; Organophosphonates; Polyomavirus Infections; Treatment Outcome; Tumor Virus Infections | 2010 |
Renal failure five years after lung transplantation due to polyomavirus BK-associated nephropathy.
Topics: Adult; Aged; Cidofovir; Cytosine; Female; Humans; Isoxazoles; Kidney Diseases; Leflunomide; Lung Transplantation; Male; Middle Aged; Mycophenolic Acid; Organophosphonates; Polyomavirus Infections; Prednisone; Renal Insufficiency; Tacrolimus; TOR Serine-Threonine Kinases | 2010 |
Acute kidney injury requiring dialysis secondary to adenovirus nephritis in renal transplant recipient.
Topics: Adenovirus Infections, Human; Aged; Antiviral Agents; Cidofovir; Cytosine; Female; Humans; Kidney; Kidney Diseases; Kidney Transplantation; Nephritis; Organophosphonates; Time Factors | 2011 |
Cidofovir may be deleterious in BK virus-associated nephropathy.
Topics: Antiviral Agents; BK Virus; Cidofovir; Cytosine; Kidney Diseases; Kidney Transplantation; Organophosphonates; Polyomavirus Infections; Retrospective Studies; Tumor Virus Infections | 2011 |
Intensive polyoma virus nephropathy treatment as a preferable approach for graft surveillance.
Topics: Adult; Antiviral Agents; Cidofovir; Cytosine; Female; Graft Rejection; Graft Survival; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Isoxazoles; Kidney Diseases; Kidney Transplantation; Leflunomide; Male; Middle Aged; Organophosphonates; Polyomavirus Infections; Tacrolimus | 2011 |
A child with BK virus infection: inadequacy of current therapeutic strategies.
Topics: BK Virus; Brain Diseases; Cardiomyopathies; Child; Cidofovir; Cytosine; Encephalomyelitis; Fatal Outcome; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney; Kidney Diseases; Organophosphonates; Polymerase Chain Reaction; Polyomavirus Infections; Viral Load | 2012 |
Cost-effectiveness of cidofovir treatment of polyomavirus nephropathy in kidney transplant recipients.
Topics: Antiviral Agents; BK Virus; Cidofovir; Cost-Benefit Analysis; Cytosine; Decision Support Techniques; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Markov Chains; Middle Aged; Models, Economic; Models, Statistical; Organophosphonates; Polyomavirus Infections; Tumor Virus Infections | 2012 |
Pharmacokinetics of low-dose cidofovir in kidney transplant recipients with BK virus infection.
Topics: Adjuvants, Pharmaceutic; Adult; Aged; Antiviral Agents; Area Under Curve; BK Virus; Cidofovir; Cross-Over Studies; Cytosine; Dose-Response Relationship, Drug; Female; Glomerular Filtration Rate; Half-Life; Humans; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Organophosphonates; Polyomavirus Infections; Probenecid; Tumor Virus Infections; Viremia | 2013 |
Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults.
Topics: Adult; Antiviral Agents; BK Virus; Child; Child, Preschool; Cidofovir; Cytosine; Female; Humans; Kidney Diseases; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Polyomavirus Infections; Prospective Studies; Tumor Virus Infections; Viral Load | 2003 |
Use of cidofovir in polyomavirus BK viral nephropathy in two renal allograft recipients.
Topics: Antiviral Agents; BK Virus; Cidofovir; Cytosine; Female; Humans; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Polyomavirus Infections; Transplantation, Homologous; Tumor Virus Infections | 2003 |
Polyoma virus nephropathy in native kidneys after lung transplantation.
Topics: Adult; Antiviral Agents; Biopsy; BK Virus; Cidofovir; Cisplatin; Cytosine; Graft Rejection; Humans; Immunosuppressive Agents; Kidney; Kidney Diseases; Lung Transplantation; Male; Mycophenolic Acid; Neoplasm Metastasis; Organophosphonates; Polyomavirus; Polyomavirus Infections; Seminoma; Steroids; Tacrolimus | 2005 |
Kidney transplant function and histological clearance of virus following diagnosis of polyomavirus-associated nephropathy (PVAN).
Topics: Adult; Antiviral Agents; Biopsy; Cidofovir; Cyclosporine; Cytosine; Female; Follow-Up Studies; Humans; Immunosuppression Therapy; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Organophosphonates; Polyomavirus Infections; Postoperative Complications; Treatment Outcome | 2006 |
BK virus-associated nephropathy in a kidney transplant recipient successfully treated with cidofovir, the first case in Japan.
Topics: Antiviral Agents; BK Virus; Cidofovir; Cytosine; Female; Humans; Japan; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Organophosphonates; Polyomavirus Infections; Tumor Virus Infections | 2008 |
Drugs for non-HIV viral infections.
Topics: 2-Aminopurine; Abnormalities, Drug-Induced; Acyclovir; Amantadine; Antiviral Agents; Cidofovir; Contraindications; Cytosine; Drug Resistance, Microbial; Eye Infections, Viral; Famciclovir; Foscarnet; Ganciclovir; Guanine; Humans; Interferon-alpha; Kidney Diseases; Lamivudine; Organophosphonates; Organophosphorus Compounds; Prodrugs; Ribavirin; Rimantadine; Trifluridine; Valacyclovir; Valine; Virus Diseases | 1997 |